Medications

Pfizer maneuvers to protect Lipitor from generics

(AP) -- Lipitor is so valuable that its maker, Pfizer Inc., is practically paying people to keep taking the blockbuster cholesterol medicine after generic competition hits the U.S. market this week.

Other

AMP opposes exclusive licensing of NIH proteomics patent

The Association for Molecular Pathology (AMP) opposed the National Institutes of Health (NIH) proposal to exclusively license the subject matter of a cancer-related proteonomics patent application filed by the Agency. AMP's ...

Other

Laser treatment can make your brown eyes blue

Just like the old Crystal Gayle song, a new laser technology could soon allow you to turn those boring brown eyes of your to a rich and beautiful blue. But you better make sure that blue eyes are what you really want because ...

Neuroscience

Scientists track neuronal stem cells using MRI

Carnegie Mellon University biologists have developed an MRI-based technique that allows researchers to non-invasively follow neural stem cells in vivo.

Health

US Congress sends Obama major patent overhaul

The US Senate Thursday passed legislation to drag the web of US patent laws into the Internet age and spur high-tech innovation, sending the measure to President Barack Obama to sign into law.

Medications

India patent case threatens cheap drug supply: MSF

Supply of cheap, copycat drugs for the developing world could be badly threatened if Swiss firm Novartis wins a challenge to India's patent law, medical charity MSF said on Monday.

page 24 from 26